Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-07-09
1985-12-03
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548318, 546271, 546278, 514341, 514392, A61K 31415, A61K 3144, C07D23370, C07D40114
Patent
active
045566658
ABSTRACT:
Novel imidazolonecarbonylarylimidazoles of the formula: ##STR1## are described having cardiovascular properties, especially as cardiotonic agents in the treatment of congestive heart failure. Pharmaceutical formulations containing such compounds are also provided. Further, a novel process for the preparation of the compounds and intermediates useful thereto of this invention is disclosed.
REFERENCES:
patent: 4367236 (1983-01-01), Grisar et al.
patent: 4405628 (1983-09-01), Dage et al.
patent: 4405635 (1983-09-01), Schnettler et al.
patent: 4447619 (1984-05-01), Grisar et al.
Erhardt Paul W.
Hagedorn, III Alfred A.
Lumma, Jr. William C.
Wohl Ronald A.
Bellamy Elizabeth A.
Briscoe Kurt G.
Millen I. William
Schering A.G.
Schwartz Richard A.
LandOfFree
Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1394917